Literature DB >> 17353902

Ligand-dependent activation of the hedgehog pathway in glioma progenitor cells.

M Ehtesham1, A Sarangi, J G Valadez, S Chanthaphaychith, M W Becher, T W Abel, R C Thompson, M K Cooper.   

Abstract

The hedgehog (Hh) signaling pathway regulates progenitor cells during embryogenesis and tumorigenesis in multiple organ systems. We have investigated the activity of this pathway in adult gliomas, and demonstrate that the Hh pathway is operational and activated within grade II and III gliomas, but not grade IV de novo glioblastoma multiforme. Furthermore, our studies reveal that pathway activity and responsiveness is confined to progenitor cells within these tumors. Additionally, we demonstrate that Hh signaling in glioma progenitor cells is ligand-dependent and provide evidence documenting the in vivo source of Sonic hedgehog protein. These findings suggest a regulatory role for the Hh pathway in progenitor cells within grade II and III gliomas, and the potential clinical utility of monitoring and targeting this pathway in these primary brain tumors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17353902     DOI: 10.1038/sj.onc.1210359

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  69 in total

Review 1.  Potential therapeutic implications of cancer stem cells in glioblastoma.

Authors:  Lin Cheng; Shideng Bao; Jeremy N Rich
Journal:  Biochem Pharmacol       Date:  2010-05-10       Impact factor: 5.858

Review 2.  Targeting Hedgehog--a cancer stem cell pathway.

Authors:  Akil A Merchant; William Matsui
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

3.  NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53.

Authors:  Marie Zbinden; Arnaud Duquet; Aiala Lorente-Trigos; Sandra-Nadia Ngwabyt; Isabel Borges; Ariel Ruiz i Altaba
Journal:  EMBO J       Date:  2010-06-25       Impact factor: 11.598

Review 4.  G protein-coupled receptors as oncogenic signals in glioma: emerging therapeutic avenues.

Authors:  A E Cherry; N Stella
Journal:  Neuroscience       Date:  2014-08-24       Impact factor: 3.590

5.  Primary orthotopic glioma xenografts recapitulate infiltrative growth and isocitrate dehydrogenase I mutation.

Authors:  J Geraldo Valadez; Anuraag Sarangi; Christopher J Lundberg; Michael K Cooper
Journal:  J Vis Exp       Date:  2014-01-14       Impact factor: 1.355

6.  Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression.

Authors:  Sreelatha Gopinath; Ramarao Malla; Kiranmai Alapati; Bharathi Gorantla; Meena Gujrati; Dzung H Dinh; Jasti S Rao
Journal:  Carcinogenesis       Date:  2012-12-07       Impact factor: 4.944

Review 7.  Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals.

Authors:  Barbara Stecca; Ariel Ruiz i Altaba
Journal:  J Mol Cell Biol       Date:  2010-01-17       Impact factor: 6.216

8.  Identification of Hedgehog pathway responsive glioblastomas by isocitrate dehydrogenase mutation.

Authors:  J Gerardo Valadez; Vandana K Grover; Melissa D Carter; M Wade Calcutt; Sunday A Abiria; Christopher J Lundberg; Thomas V Williams; Michael K Cooper
Journal:  Cancer Lett       Date:  2012-10-11       Impact factor: 8.679

9.  NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200.

Authors:  Junsheng Fu; Mariana Rodova; Rajesh Nanta; Daniel Meeker; Peter J Van Veldhuizen; Rakesh K Srivastava; Sharmila Shankar
Journal:  Neuro Oncol       Date:  2013-03-12       Impact factor: 12.300

10.  Targeted inhibition of the Hedgehog pathway in established malignant glioma xenografts enhances survival.

Authors:  A Sarangi; J G Valadez; S Rush; T W Abel; R C Thompson; M K Cooper
Journal:  Oncogene       Date:  2009-07-20       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.